4//SEC Filing
Kim Lorence H. 4
Accession 0001567619-22-013970
CIK 0001628171other
Filed
Jul 12, 8:00 PM ET
Accepted
Jul 13, 5:02 PM ET
Size
7.0 KB
Accession
0001567619-22-013970
Insider Transaction Report
Form 4
Kim Lorence H.
Director
Transactions
- Award
Common Stock
2022-07-12+10,500→ 10,500 total - Award
Stock Option (Right to Buy)
2022-07-12+36,800→ 36,800 totalExercise: $22.48Exp: 2032-07-11→ Common Stock (36,800 underlying)
Footnotes (2)
- [F1]Includes 10,500 Restricted Stock Units.
- [F2]The option becomes exercisable as it vests and the shares subject to the option vest with respect to 1/36 of the shares subject thereto on each monthly anniversary of July 12, 2022, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date.
Documents
Issuer
Revolution Medicines, Inc.
CIK 0001628171
Entity typeother
Related Parties
1- filerCIK 0001643746
Filing Metadata
- Form type
- 4
- Filed
- Jul 12, 8:00 PM ET
- Accepted
- Jul 13, 5:02 PM ET
- Size
- 7.0 KB